CLINICAL_TRIALS
trial_result
· 2025-06-03
Clinical Trial Update: A Phase 2 Study of E6005 in Patients With Atopic Dermatitis [Phase 2]
Summary
A Phase 2 study evaluating the investigational agent E6005 in patients with Atopic Dermatitis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Organon and Co | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED